JP Morgan Downgrades Insulet to Neutral, Lowers Price Target to $152
Benzinga Newsdesk 2 months ago
NewsDowngradesAnalyst RatingsPrice Target
JP Morgan analyst Robbie Marcus downgrades Insulet (NASDAQ:PODD) from Overweight to Neutral and lowers the price target from $275 to $152.
JP Morgan analyst Robbie Marcus downgrades Insulet (NASDAQ:PODD) from Overweight to Neutral and lowers the price target from $275 to $152.